BiosimilarFollow-on Biologic, Subsequent Entry Biologic
A biological product highly similar to an approved reference biologic, with no clinically meaningful differences in safety, purity, or potency.
Terms for how medicine prices are set and negotiated and how patients gain access to new treatments.
A biological product highly similar to an approved reference biologic, with no clinically meaningful differences in safety, purity, or potency.